Last reviewed · How we verify
Diabetic peripheral neuropathy
Approved treatments
- Cymbalta · Eli Lilly and Company
Potentiates serotonergic and noradrenergic activity in the CNS through unknown exact mechanisms. - Tarlige · Daiichi Sankyo
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Diabetic peripheral neuropathy patent landscape — cliff calendar, originator estates, attackable patents
- Diabetic peripheral neuropathy treatment landscape brief
- Diabetic peripheral neuropathy treatment updates RSS
Frequently asked questions about Diabetic peripheral neuropathy
What drugs treat Diabetic peripheral neuropathy?
Tracked treatments include Cymbalta, Tarlige.
What is the treatment for Diabetic peripheral neuropathy?
Standard treatment for Diabetic peripheral neuropathy includes Cymbalta, Tarlige. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Diabetic peripheral neuropathy patent cliff · Diabetic peripheral neuropathy CI report
- Treatment: Cymbalta · Eli Lilly and Company
- Treatment: Tarlige · Daiichi Sankyo
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing